IL-17A is strongly associated with certain autoimmune diseases, such as psoriasis, rheumatoid arthritis, and Crohn’s disease, with FDA-approved inhibitors of IL-17A used in treatment of some of these conditions (15, 17). Here, IL17A is linked to autoimmune disease.